Injectable / Weight Loss & GLP-1
Cagri + Sema
Amylin-GLP-1 Dual Agonist
$239 USD per unit · Coming soon · Dual vial kit
The most advanced metabolic peptide pairing available. Amylin analog combined with GLP-1 for unparalleled appetite regulation.
Product information
This premium combination pairs cagrilintide (a long-acting amylin analog) with semaglutide (GLP-1 receptor agonist), targeting two distinct but complementary appetite regulation pathways.
Amylin and GLP-1 act on different brain regions to suppress appetite, slow gastric emptying, and regulate glucose metabolism. Clinical data suggests this combination may produce the most significant weight management outcomes of any peptide protocol.
Benefits
- Dual amylin + GLP-1 pathway activation
- Superior appetite suppression
- Synergistic metabolic optimization
- Advanced body composition support
Specifications
- Fill / pack
- Dual vial kit
- Format
- Injectable
- Serving
- Per protocol
- Servings per container
- 8 week protocol
- Listed purity
- 99.5%+ both
- Molecular weight / composition
- Dual peptide
- Storage
- Refrigerate 2-8°C
Frequently asked questions
How should I store this product?
Refrigerate at 2-8°C. Keep away from direct light. Once reconstituted, use within 30 days.
How long until I see results?
Most users report initial effects within 2-4 weeks, with optimal results typically observed after 8-12 weeks of consistent use. Individual responses vary.
Is a Certificate of Analysis included?
Yes. Every order includes a batch-specific COA with HPLC purity analysis, amino acid sequence verification, and endotoxin testing results.
How do I apply this product?
Apply to clean, dry skin. For serums, use 2-3 drops and gently pat into the skin. Allow to absorb before applying other products.
For laboratory and research use only. Not for human consumption.
Browse all peptide bioregulators or the Weight Loss & GLP-1 collection. All formulations.